Skip to Main Content

Author Details

Andrea V Gamarnik
Fundacion Instituto Leloir-CONICET
1991
75
38
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37252973Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation.Proc Natl Acad Sci U S A2023
38022542Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.Front Immunol2023
37090429Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2.Heliyon2023
34709638Dengue Virus Capsid-Protein Dynamics in Live Infected Cells Studied by Pair Correlation Analysis.Methods Mol Biol2022
35736223Insights into the product release mechanism of dengue virus NS3 helicase.Nucleic Acids Res2022
35790807Author Correction: In vivo pair correlation microscopy reveals dengue virus capsid protein nucleocytoplasmic bidirectional movement in mammalian infected cells.Sci Rep2022
35723970Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response.J Infect Dis2022
35777383Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people.Lancet Infect Dis2022
36248791Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.Front Immunol2022
35926505Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.Cell Rep Med2022
36263055SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.Front Immunol2022
35073758Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time.mBio2022
35310416Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires.Front Vet Sci2022
35305316Antibody durability at 1 year after Sputnik V vaccination.Lancet Infect Dis2022
33232588A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.N Engl J Med2021
33906129Severe acute respiratory syndrome coronavirus 2019. Seroepidemiology study in Argentinian slum.Medicina (B Aires)2021
33593976Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.mBio2021
34952906In vivo pair correlation microscopy reveals dengue virus capsid protein nucleocytoplasmic bidirectional movement in mammalian infected cells.Sci Rep2021
34375636Dengue and Zika virus capsid proteins bind to membranes and self-assemble into liquid droplets with nucleic acids.J Biol Chem2021
34013833Extracellular acidosis enhances Zika virus infection both in human cells and ex-vivo tissue cultures from female reproductive tract.Emerg Microbes Infect2021
34308389Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.Cell Rep Med2021
33444413Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina.PLoS Pathog2021
32432721Dengue virus targets RBM10 deregulating host cell splicing and innate immune response.Nucleic Acids Res2020
32581095Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.J Virol2020
32817961Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera.medRxiv2020
32472078Dengue Virus Capsid Protein Dynamics Reveals Spatially Heterogeneous Motion in Live-Infected-Cells.Sci Rep2020
30622191RNA Structure Duplication in the Dengue Virus 3' UTR: Redundancy or Host Specificity?mBio2019
31472473De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.Eur J Med Chem2019
31332207Thermodynamic study of the effect of ions on the interaction between dengue virus NS3 helicase and single stranded RNA.Sci Rep2019
28668194Discovery of novel dengue virus entry inhibitors via a structure-based approach.Bioorg Med Chem Lett2017
28264033Dengue virus genomic variation associated with mosquito adaptation defines the pattern of viral non-coding RNAs and fitness in human cells.PLoS Pathog2017
26789921Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.Immunity2016
27501261Properties and Functions of the Dengue Virus Capsid Protein.Annu Rev Virol2016
27353759Dengue Virus Genome Uncoating Requires Ubiquitination.mBio2016
27575636The Dengue Virus NS5 Protein Intrudes in the Cellular Spliceosome and Modulates Splicing.PLoS Pathog2016
27009958A Proline-Rich N-Terminal Region of the Dengue Virus NS3 Is Crucial for Infectious Particle Production.J Virol2016
26850219RNA Structure Duplications and Flavivirus Host Adaptation.Trends Microbiol2016
25589642Overlapping local and long-range RNA-RNA interactions modulate dengue virus genome cyclization and replication.J Virol2015
26031340Dengue Virus Uses a Non-Canonical Function of the Host GBF1-Arf-COPI System for Capsid Protein Accumulation on Lipid Droplets.Traffic2015
25635835Dengue virus RNA structure specialization facilitates host adaptation.PLoS Pathog2015
25223789Monomeric nature of dengue virus NS3 helicase and thermodynamic analysis of the interaction with single-stranded RNA.Nucleic Acids Res2014
23526990Steady-state NTPase activity of Dengue virus NS3: number of catalytic sites, nucleotide specificity and activation by ssRNA.PLoS One2013
23760236Differential RNA sequence requirement for dengue virus replication in mosquito and mammalian cells.J Virol2013
22072762Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation.J Virol2012
22558403Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase.PLoS One2012
22624001An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.PLoS One2012
21183683RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase.J Biol Chem2011
21994804Functional RNA elements in the dengue virus genome.Viruses2011
21593583Dynamic RNA structures in the dengue virus genome.RNA Biol2011
21471248The F1 motif of dengue virus polymerase NS5 is involved in promoter-dependent RNA synthesis.J Virol2011
  • 1 - 50 of 75

Recommended Authors

Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year 2017
Number of shared co-authors 4
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 4
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 7
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 3
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 3
Xuping Xie
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 6
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 4
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 15
Koen Bartholomeeusen
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 2
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 0
Rachel L Graham
University of North Carolina
Career Start Year 2004
Number of shared co-authors 1
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 2
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 3
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2001
Number of shared co-authors 12
Benjamin R tenOever
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 15
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 5
Sonia Zu??iga
Campus Universidad Autonoma de Madrid
Career Start Year 1999
Number of shared co-authors 2
Daisy W Leung
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 6
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 7
Ian Goodfellow
University of Cambridge
Career Start Year 1996
Number of shared co-authors 5
Philippe Le Mercier
carnegie mellon university
Career Start Year 1996
Number of shared co-authors 0
Isabel Sola
Campus Universidad Autonoma de Madrid
Career Start Year 1995
Number of shared co-authors 2
John Ziebuhr
Institute of Medical Virology Justus Liebig University
Career Start Year 1995
Number of shared co-authors 1
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 3
Sara Cherry
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 7
Brett D Lindenbach
Yale University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 8
Steven G Widen
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 5
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 6
Charles M Rice
Rockefeller University
Career Start Year 1981
Number of shared co-authors 8

Collaborators

Leopoldo G Gebhard
Fundacion Instituto Leloir-CONICET
Co-authored papers 15
N??stor G Iglesias
Fundacion Instituto Leloir-CONICET
Co-authored papers 12
Diego S Ojeda
Fundacion Instituto Leloir-CONICET
Co-authored papers 12
Mar??a Mora Gonzalez Lopez Ledesma
Fundacion Instituto Leloir-CONICET
Co-authored papers 11
Raul Andino
University of California san francisco
Co-authored papers 9
Horacio M Pallar??s
Fundacion Instituto Leloir-CONICET
Co-authored papers 8
Guadalupe Navarro
Fundacion Instituto Leloir-CONICET
Co-authored papers 7
Ana Ceballos
Instituto Medico Rio Cuarto
Co-authored papers 6
Santiago Oviedo Rouco
Fundacion Instituto Leloir-CONICET
Co-authored papers 5
Luana Pereira Borba-Santos
Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro
Co-authored papers 5
Federico A De Maio
Fundacion Instituto Leloir-CONICET
Co-authored papers 5
Marcelo J Yanovsky
Fundacion Instituto Leloir
Co-authored papers 4
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 3
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Priya S Shah
University of California davis
Co-authored papers 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Anabella Srebrow
Universidad de Buenos Aires
Co-authored papers 2
Ana Paletta
Co-authored papers 2
Sebastian Aguirre
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Co-authored papers 2
Michael Jacobs
Royal Free NHS Foundation Trust
Co-authored papers 2
Jeremy P Kamil
Louisiana State University Health Sciences Center Shreveport
Co-authored papers 2
Pablo Mammi
Universidad de Buenos Aires
Co-authored papers 2
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Jean K Lim
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Berta Pozzi
Institute of Cell Biology, University of Bern
Co-authored papers 2
Jennifer R Hamilton
University of California berkeley
Co-authored papers 1
Camilla Melegari
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Mar??a A Lacaze
Co-authored papers 1
David Sachs
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Estefan??a Mancini
Fundacion Instituto Leloir
Co-authored papers 1
Release 1.2